Silence Therapeutics shares rise following positive Phase 1 SANRECO study data for divesiran

Statements (3)

1. ● Neutral

   Silence Therapeutics plc (SLN) is listed on NASDAQ under ticker SLN

   finance.yahoo.comJun 30, 2026 13:06 UTC
2. ▲ Bullish

   Silence Therapeutics shares are likely to rise following positive Phase 1 SANRECO study data for divesiran.

   benzinga.comJun 12, 2026 14:47 UTC
3. ▲ Bullish

   Silence Therapeutics shares rose during Friday's session following positive Phase 1 SANRECO study data for divesiran.

   benzinga.comJun 12, 2026 14:47 UTC